COV, PWRM, MSFT, CSRH, NKE, CVAT, ABT, DrStockPick.com Stock Report!
Dr Stock Pick HOT News & Alerts!
_________________________________________
FREE Daily Stock Alerts From DrStockPick.com
_________________________________________
Wednesday September 30, 2009
DrStockPick.com Stock Report!
COV, PWRM, MSFT, CSRH, NKE, CVAT, ABT
**************************************************************
COV, Covidien plc
COV engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings worldwide. The company operates through four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products, and Medical Supplies.
COV said Wednesday it received Food and Drug Administration clearance for its new endotracheal tube, a device that helps patients breathe.
**************************************************************
PWRM, Power 3 Medical Products Inc, PWRM.OB
Power3 Medical Products, Inc. is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets. Diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro). Power3 expects to complete phase II clinical validation trials of its blood serum diagnostics for Alzheimer’s disease (NuroPro-AD), and Parkinson’s disease (NuroPro-PD) in 2009 and for breast cancer in 2010, followed by filings with the FDA. Power3 operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas. Power3 continues to evolve and enhance its IP portfolio, employing sensitive and specific combinations of biomarkers it has discovered from a broad range of diseases as the basis of highly selective blood-based tests for ALS, Alzheimer’s, and Parkinson’s diseases, and breast cancer.
PWRM Announced that its Chief Scientific Officer is Chair and Keynote Speaker of Session at the BTI Life Sciences 2nd Annual Congress and Expo of Molecular Diagnostics in Beijing, China in November 2009
Further international recognition of validity as the company’s President and CSO, Dr. Ira Goldknopf will deliver an invited Keynote address and chair a session on “Biomarkers and Diagnostics in Personalized Medicine (Track 6-4),” at the BIT Life Sciences 2nd International Congress and Expo of Molecular Diagnostics in Beijing, China, November 19-21, 2009. The Theme of the meeting is “New Leadership of Personalized Medicine.”
More about PWRM at www.power3medical.com
**************************************************************
NKE, Nike Inc.
NKE designs, develops, and markets footwear, apparel, equipment, and accessory products worldwide. The company offers various categories of shoes, including running, training, basketball, soccer, sport-inspired urban shoes, and kids? shoes. It also provides shoes for aquatic activities, baseball, football, cheerleading, golf, lacrosse, outdoor activities, skateboarding, tennis, volleyball, walking, wrestling, and various athletic and recreational uses.
NKE’s fiscal first-quarter profit topped Wall Street expectations
**************************************************************
CSRH, Consorteum Holdings Inc, CSRH.OB
CSRH is a company in the financial services, payment and transaction processing industries.
CSRH provides electronic transaction processing and management services to financial institutions, healthcare, government, public and private sector companies. CSRH’s services provide customized, innovative technology solutions that create, augment and enhance customers’ existing financial, payment and transactional processing systems.
CSRH has established an agreement with a third party partner within the payment processing industry to offer Merchant Discount Rates. Consorteum will leverage this new partnership to offer competitive Merchant Discount Rates and Point of Sale hardware to its new and existing client base.
Quent Rickerby, President & COO of Consorteum Holdings Inc., said, “This agreement will allow Consorteum to offer Canadian clients measurable cost savings on their Credit and Debit Card processing and further enhance the number of products and services we have available.”
Consorteum’s new Merchant Discount Rate program further enhances its list of financial services available to current and future clients. The addition of generating new revenues from debit and credit card transaction processing will ensure long-term revenue growth and incremental residual income. Consorteum will continue to expand its portfolio of financial services, which will further grow the revenues of the company, ensuring increased shareholder value. Processors in North America process in excess of 75 billion electronic payment transactions annually.
More about CSRH at www.consorteum.com
**************************************************************
CVAT, Cavitation Technologies Inc, CVAT.OB
CVAT is a “Green-Tech” company, established in 2006 to become a world leader in the development of new cutting edge technologies for the, vegetable oil refining, renewable fuel, petroleum, water treatment, wastewater sanitation, petroleum, food and beverage, chemical industries.
CVAT announce Producer’s Choice Soy Energy (www.pcsoyenergy.com) Moberly, MO biodiesel production plant is performing above expectations.
According to Charles Mandeville, Chemist, SRS Engineering, Inc. “The CTI BioForce 9000 is doing its job very well, providing excellent conversion rates, exceeding all our expectations and performance requirements. The fuel quality is the best we have ever seen.”
Roman Gordon, CTI CEO, stated, “We knew that our unit would provide excellent performance and are very pleased by this news confirming our technology performs much better than others. We believe there is a bright future for BioForce 9000, which offers many advantages for new production plants, which gives them an edge over other producers. Feedstock flexibility, higher yields and top quality fuel will allow plants to be more profitable than existing producers. This will show existing plants that by replacing older outdated technologies, they can improve profitability as well.” Mr. Gordon went on further to say, “We have many clients who are now moving forward with their projects for new plants in South America, Asia and other parts of the world.”
CTI’s BioForce 9000 nano-cavitation biodiesel reactor is a unique low cost single stage reactor and is the most advanced system available today for quality biodiesel production. The BioForce 9000 offers substantial savings over existing technologies, which reduce equipment, and production costs substantially. Its ability to process multiple feedstocks and reduce energy costs is a significant advantage for producers.
The Producer’s Choice Soy Energy is the first of many companies, which are planning to utilize CTI’s BioForce 9000 and SRS systems technologies. The plant was designed and constructed by Process Concepts (www.processconcepts.com) and SRS Engineering, Inc. (www.srsengineering.com). CTI is also working with Desmet Ballestra, the world’s leading provider of biodiesel plants, to install the CTI BioForce 9000 in some of their plants.
CVAT More about CVAT at www.cavitationtechnologies.com
**************************************************************
MSFT, Microsoft Corporation
MSFT provides software and hardware products and solutions worldwide. The Client segment offers Windows Vista comprising Home Basic, Home Premium, Ultimate, Business, Enterprise, and Starter editions; and Windows XP, including Professional, Home, Media Center, and Tablet PC editions.
A federal judge in Rhode Island has thrown out a $388 million patent infringement jury verdict against MSFT.
**************************************************************
ABT, Abbott Laboratories
ABT manufactures and sells health care products worldwide. The company’s Pharmaceutical Products segment offers adult and pediatric pharmaceuticals for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, Crohn’s disease, dyslipidemia, HIV infection, hypothyroidism, advanced prostate cancer, endometriosis and central precocious puberty, anemia caused by uterine fibroids, obesity, epilepsy and bipolar disorder, migraines, and secondary hyperparathyroidism; and provides anesthesia products and anti-infectives.
ABT announced today that it has significantly reduced its use of both fossil fuels and electricity as part of a multi-faceted, company-wide effort to safeguard the environment and reduce energy costs across all of its global health care businesses.
**************************************************************
Keep a close eye on COV, PWRM, MSFT, CSRH, NKE, CVAT and ABT do your homework, and like always BE READY for the ACTION!
***********Advertisement***********
********************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com End Of day publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.
Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick Stock Watch report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.
Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services for Power 3 Medical Products Inc. (PWRM.OB). Crown Equity Holdings, Inc. (CRWE.OB) has received five thousand shares of free trading stock from a third party for advertising services for Cavitation Technologies, Inc. (CVAT.OB) and an additional twenty-five thousand shares of 144 restricted stock from Cavitation Technologies, Inc. (CVAT.OB) for 12 months of advertisement services. Crown Equity Holdings, Inc. (CRWE.OB) has received five thousand dollars from Consorteum Holdings Inc. for 30 days of advertisement services. Crown Equity Holdings, Inc. (CRWE.OB) has received 78,000 free trading and 500,000 144 (restricted) shares from a third party for 6 months of advertising services Consorteum Holdings Inc, (CSRH.OB)
_______________________________________________________
_______________________________________________________
Dr. Stock Pick
is a seasoned equity trader and financial investor. He’s on the Crown Equity Holdings, Inc (CRWE.OB) financial staff as a professional investment analyst and consultant. He’s syndicated on over 1000 websites www.crwenews.com, www.stock-ir.com giving daily, up to the minute information about stocks, options, currencies and more. www.drstockpick.com
email: investor@drstockpick.com
Dr Stock Pick would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
